Paclitaxel AHP 150mg injection

Paclitaxel AHP 150mg Injection contains paclitaxel, a cytotoxic chemotherapy medicine from the taxane group. It is used in specialist cancer-treatment protocols for certain breast, ovarian, non-small-cell lung, pancreatic, and other cancers, depending on the diagnosis and treatment plan. Paclitaxel stabilizes microtubules inside cells, preventing cancer cells from dividing and multiplying normally. It must be diluted and administered through an intravenous infusion by trained oncology professionals in a properly equipped healthcare facility. The dose is calculated according to body surface area, cancer type, treatment schedule, liver function, blood counts, and other medicines being given. Premedication is usually required to reduce the risk of serious hypersensitivity reactions. Common adverse effects include reduced blood-cell counts, infection risk, hair loss, nausea, tiredness, mouth ulcers, muscle or joint pain, and numbness or tingling in the hands and feet. Blood counts and liver function require monitoring before treatment cycles. Paclitaxel may harm an unborn baby; effective contraception is necessary during treatment as directed. Seek immediate medical assistance for fever, breathing difficulty, facial swelling, chest discomfort, unusual bleeding, severe weakness, or signs of infection. This medicine must never be self-administered.

Price: Rs. 16790.00

• Manufacturer
  Al Habib Pharmaceutical
• Generic name
  Paclitaxel
• Pack size
  1 Vial injection
• Availability
  In stock
• Prescription required
  Yes